Physician profile
Christopher T Nelson
NPI 1164442240
$739.19
in general payments reported to CMS, 2019-2025
18 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $54.98 · 2022: $59.74 · 2023: $128 · 2024: $166 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $191.49 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $80.53 | 2022-2025 | Gardasil 9, Rotateq, M-M-R II |
| Ironshore Pharmaceuticals INC. | $73.22 | 2019-2020 | |
| Cranial Technologies, INC | $56.46 | 2024-2025 | Doc Band |
| Pfizer INC. | $41.99 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $41.09 | 2022 | |
| Acadia Pharmaceuticals INC | $29.52 | 2023 | Daybue |
| Tris Pharma INC | $28.18 | 2019-2025 | Onyda Xr |
| Glaxosmithkline, LLC. | $25.21 | 2019-2020 | |
| Genentech USA, INC. | $24.66 | 2019-2020 | |
| Biomarin Pharmaceutical INC. | $24.64 | 2025 | Voxzogo 1.2mg |
| Ars Pharmaceuticals Operations, INC. | $24.11 | 2025 | Neffy |
| Phadia US INC. | $23.22 | 2025 | Immunocap |
| Takeda Pharmaceuticals U.S.A., INC. | $17.92 | 2019 | |
| Verrica Pharmaceuticals INC. | $16.18 | 2024 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $14.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.52 | 2024 | Flumist Quadrivalent |
| Kaleo, INC. | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.